Search for a command to run...
SMS Pharmaceuticals Ltd. shows promising growth metrics but is positioned within a competitive landscape where peers excel in profitability and efficiency. The company demonstrates solid revenue growth, yet its valuation metrics suggest it may be on the higher end compared to some peers with stronger margins and lower valuations.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
SMSPHARMA | ₹237.90 | ₹2,109.03Cr | 30.84 | 11.73% | 0.55 |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |